FOXO Technologies
Minneapolis
About FOXO Technologies
FOXO Technologies is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights.FOXO Technologies Inc. uses AI-driven bioinformatics and microarray technologies to develop and commercialize epigenetic biomarkers of health and aging. FOXO provides insurers, health researchers, and life science companies with laboratory services, microarray design, and AI-driven bioinformatics software solutions for generating novel health-based insights into lifespan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $68.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: nysemkt:FOXO
- Website: foxotechnologies.com
- Phone: +1 612 800-0059
Industries & Categories
Bioinformatics, Biotechnology, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/foxo-technologies-97508 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.